Ranibizumab (inzira yo mu jisho)
Amoko ahari
Byooviz, Cimerli, Lucentis, Susvimo
Ibyerekeye uyu muti
Ranibizumab ikoreshwa mu kuvura indwara y'amaso y'abakuze iterwa no kwiyongera kw'imijyana y'amaraso (wet AMD). Susvimo™ ikoreshwa ku barwayi bagaragaje igikorwa cyiza nyuma y'inkingo ebyiri cyangwa zirenze za vascular endothelial growth factor (VEGF) inhibitor. AMD ni indwara y'urukiramende rw'ijisho itera kwangirika k'ububone cyangwa ubuhumyi. Ranibizumab ikora mu guhindura umubare w'amaraso agera mu jisho. Ranibizumab kandi ikoreshwa mu kuvura myopic choroidal neovascularization (mCNV). Ranibizumab ikoreshwa mu kuvura macular edema (kubyimba inyuma y'ijisho) nyuma ya retinal vein occlusion (uburyo bw'amaraso mu jisho bukingiranye). Ikoreshwa kandi ku barwayi ba diyabete bafite diabetic macular edema (DME). Macular edema ishobora gutera igihombo cy'ububone. Ubu buti imiti kandi ikoreshwa mu kuvura diabetic retinopathy (ikibazo cy'amaso giterwa na diyabete). Iyi miti igomba gutangwa gusa na muganga cyangwa munsi y'ubuyobozi bwa muganga. Iyi miti iboneka mu buryo bukurikira:
Mbere yo gukoresha uyu muti
Mu gufata icyemezo cyo gukoresha imiti, ibyago byo gufata iyo miti bigomba guhanurwa n'akamaro izagira. Iki ni icyemezo uzatanga hamwe na muganga wawe. Kuri iyi miti, ibi bikurikira bigomba kwitabwaho: Bwira muganga wawe niba wigeze ugira uburwayi budasanzwe cyangwa ubwirinzi ku miti cyangwa izindi miti. Nanone, bwira umuhanga mu by'ubuzima ufite andi moko y'ubwirinzi, nko ku biribwa, amabara, ibintu birinda kwangirika, cyangwa inyamaswa. Ku bicuruzwa bitagomba kwandikwa na muganga, soma witonze ibikubiye kuri etiketi cyangwa ubusobanuro bw'ibintu birimo. Ubushakashatsi bukwiye ntabwo bwakozwe ku isano iri hagati y'imyaka n'ingaruka za ranibizumab ku bana. Ubuziranenge n'ingaruka nziza ntibyarangiye. Ubushakashatsi bukwiye bwakozwe kugeza ubu ntabwo bwerekanye ibibazo byihariye by'abageze mu za bukuru byazagabanya ingaruka za ranibizumab ku bakuze. Nta bushakashatsi buhagije ku bagore bwo kumenya ibyago by'uruhinja mu gihe ukoresha iyi miti mu gihe cyo konsa. Pima inyungu zishoboka ugereranije n'ibyago bishoboka mbere yo gufata iyi miti mu gihe cyo konsa. Nubwo imiti imwe n'imwe idakwiye gukoreshwa hamwe na gato, mu bindi bihe imiti ibiri itandukanye ishobora gukoreshwa hamwe nubwo hariho ikibazo gishobora kubaho. Muri uru rubanza, muganga wawe ashobora kwifuza guhindura umwanya, cyangwa izindi ngamba zishobora kuba ngombwa. Bwira umuhanga mu by'ubuzima ufite indi miti yose yanditswe na muganga cyangwa itanditswe na muganga (over-the-counter [OTC]). Imiti imwe n'imwe ntikwiye gukoreshwa mu gihe cyo kurya cyangwa hafi yacyo cyangwa kurya imirire imwe n'imwe kuko hariho ikibazo gishobora kubaho. Gukoresha inzoga cyangwa itabi hamwe n'imiti imwe nabyo bishobora gutera ibibazo. Gabagana n'umuhanga mu by'ubuzima wawe gukoresha imiti yawe hamwe n'ibiribwa, inzoga cyangwa itabi. Kuba hari ibindi bibazo by'ubuzima bishobora kugira ingaruka ku ikoreshwa ry'iyi miti. Menya neza kubwira muganga wawe niba ufite ibindi bibazo by'ubuzima, cyane cyane:
Uburyo bwo gukoresha uyu muti
Lucentis®:Umuganga w’amaso azaguha iyi miti nk'urushinge mu jisho. Iyi miti isanzwe itangwa rimwe mu kwezi (hafi buri minsi 28). Mu barwayi bamwe, ishobora gutangwa rimwe mu mezi atatu nyuma y'injeksiyonu enye za mbere. Susvimo™:Iyi miti ni ikintu gishyirwa mu jisho, gishyirwa mu gice cyera cy'ijisho (sclera) na muganga. Muganga wawe azongera gushyiramo iki kintu buri mezi atandatu (byibuze buri byumweru 24). Muganga wawe azakugira inama yo gukurikiza nyuma yo kubona iki kintu cyangwa nyuma yo kongera gushyirwamo, ndetse n'inyuma y'aho iki kintu cyakuweho. Iyi miti igomba kuza ifite amabwiriza y'imiti. Soma kandi ukureba aya mabwiriza neza. Baza muganga wawe niba ufite ikibazo. Hamagara muganga wawe cyangwa umuganga w'imiti kugira ngo akugire inama.
Umuhakana: Kanama ni urubuga rw'amakuru y'ubuzima kandi ibisubizo byayo ntibigize inama z'ubuvuzi. Jya ubona umuganga ufite uruhushya rwo gukorera hafi yawe mbere yo gukora impinduka izo ari zo zose.